Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Insulet and Dexcom agree to develop wireless, handheld personal diabetes monitor

Insulet : 08 January, 2008  (New Product)
Insulet and DexCom have signed a development agreement to integrate DexCom's continuous glucose monitoring technology into Insulet wireless, handheld OmniPod System Personal Diabetes Manager (PDM).
In addition to programming the patient's insulin delivery, the PDM with integrated DexCom technology will receive and display continuous glucose readings from DexCom's wearable sensor transmitter. Patients using the integrated system will have access to real-time glucose values and trended glucose information, as well as alarms to warn patients if glucose levels are rising or falling.

'Insulet is a leader in diabetes technology. This development agreement with DexCom is another example of Insulet's commitment to improving the lives of people with diabetes through innovation,' said Duane DeSisto, president and chief executive officer of Insulet. 'Integrating DexCom's technology into the OmniPod PDM will combine the proven benefits of insulin pump therapy and continuous glucose monitoring in a single safe, discreet and easy-to-use system.'

Terrance H Gregg, president and chief executive officer of DexCom added, 'We are pleased to work with Insulet to bring these two leading-edge technologies together to help people living with diabetes better manage their disease.'

The PDM with DexCom technology will combine the functionality of both systems' handheld receivers into one single handheld wireless device, eliminating the need for a separate receiver. The PDM will be used to program the wearable OmniPod with insulin delivery instructions and will also receive and display continuous glucose readings directly from DexCom's wearable sensor transmitter.

The integrated system will provide patients with continuous information about glucose levels and allow patients to continuously track trends, enabling them to accurately anticipate excursions outside of normal glucose levels and to make appropriate treatment adjustments. Alarms on the PDM will immediately alert the patient when glucose levels are outside of the target range, allowing the patient the opportunity to intervene and prevent acute events. Development, clinical and regulatory efforts are expected to continue throughout 2008, with an anticipated product launch in mid-2009.

The PDM with integrated DexCom technology will broaden Insulet's portfolio of diabetes management products. The development agreement between Insulet and DexCom also contemplates further work by Insulet and DexCom towards development of a closed-loop system.

The agreement is non-exclusive and does not impact any of Insulet's existing third party development agreements.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo